DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

H.C. Wainwright Maintains Buy on TRACON Pharmaceuticals, Lowers Price Target to $6

H.C. Wainwright maintains TRACON Pharmaceuticals (NASDAQ:TCON) with a Buy and lowers the price target from $13 to $6.

Benzinga · 03/10/2020 11:36

H.C. Wainwright maintains TRACON Pharmaceuticals (NASDAQ:TCON) with a Buy and lowers the price target from $13 to $6.